Clinical trial
Evaluation of Topical Vigamox in the Initial Management of Ocular Graft-Versus-Host Disease
NCT04204122 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Topical Vigamox in the Initial Management of Ocular Graft-Versus-Host Disease
- Lead sponsor
- Washington University School of Medicine
- Phase
- Phase 2
- Overall status
- Withdrawn
- Start date
- June 15, 2020
- Completion date
- March 31, 2025
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
ocular graft-versus-host disease